Quinnova Pharmaceuticals
Newtown · Founded 2003
About Quinnova Pharmaceuticals
Quinnova Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercial sale of prescription drug products based on dermal drug delivery platforms. It offers HYDRO 40 foam, a dry skin treatment product; tersi foam, a leave-on foam indicated for the treatment of seborrheic dermatitis and tinea versicolor; rinnovi nail system, a prescription nail system that is designed to clean, treat, and protect diseased, damaged, brittle, and ingrown nails; and cleanse and treat, a pad delivery technology system for the treatment of acne. Quinnova Pharmaceuticals, Inc. was founded in 2003 and is based in Newtown, Pennsylvania.
Company Facts
- Founded: 2003
- Legal name: Quinnova Pharmaceuticals, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $31.3M
- Funding stage: Early Stage Venture
- Last round: Convertible Note (Sep 2010)
- Website: quinnova.com
- Phone: +1 215-860-6263
Canonical: https://fsome.com/organization/quinnova-pharmaceuticals-8427488 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.